No abstract available
MeSH terms
-
Administration, Intravenous
-
Anti-Bacterial Agents / administration & dosage
-
Antifungal Agents / administration & dosage
-
Ascites* / etiology
-
Ascites* / microbiology
-
Ascites* / therapy
-
Ascitic Fluid / microbiology*
-
Ascitic Fluid / pathology
-
Candida albicans / isolation & purification*
-
Ertapenem
-
Escherichia coli / isolation & purification
-
Escherichia coli / pathogenicity
-
Escherichia coli Infections / complications
-
Escherichia coli Infections / diagnosis
-
Escherichia coli Infections / drug therapy
-
Escherichia coli Infections / physiopathology
-
Fatal Outcome
-
Female
-
Fluconazole / administration & dosage*
-
Hepatic Encephalopathy / etiology*
-
Hepatitis C / complications
-
Humans
-
Liver Cirrhosis* / complications
-
Liver Cirrhosis* / diagnosis
-
Liver Cirrhosis* / microbiology
-
Liver Cirrhosis* / physiopathology
-
Middle Aged
-
Paracentesis / methods
-
Shock, Septic / etiology
-
beta-Lactams / administration & dosage
Substances
-
Anti-Bacterial Agents
-
Antifungal Agents
-
beta-Lactams
-
Fluconazole
-
Ertapenem